Company: CNTB
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001835268-25-000058
Chunk: 67

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 8
Chunk 67
---
4, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Filed32.1#Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Furnished101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentFiled101.SCHInline XBRL Taxonomy Extension Schema DocumentFiled101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentFiled101.DEFInline XBRL Taxonomy Definition Linkbase DocumentFiled101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentFiled101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled104Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)Filed

# The certifications attached as Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

29